Home / Brands / Slate Run Pharmaceuticals
Slate Run Pharmaceuticals Recalls
3 recalls on record · March 26, 2025 to March 4, 2026 · Drugs
Recalls by year
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 4, 2026DrugsFDA
Slate Run Pharmaceuticals recalls Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous U
Hazard: Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
March 26, 2025DrugsFDA
Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 4321
Hazard: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
March 26, 2025DrugsFDA
Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 4321
Hazard: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.